Topic Archives: lung cancer

So now, more than six months after this pandemic was officially declared, some experts are telling us that the COVID-19 testing that we have been doing is all wrong, and that a totally different form of testing could be an effective way to end the pandemic.   What they are saying is that the scientific […]

Comments

  • OCX had big news today with success with its lung cancer treatment. Jumped up over 30% this morning, now up about 20%. M...

  • Recently I became aware of a YouTube by Dr Andrew Kaufman and exosomes. Dr Kaufman maintains that these normal cellular ...

  • Medical errors...third leading cause of death in US. This includes prescribed medicines taken as ordered by doctors, no...

  • Not to be a downer, my brother died of brain and lung Cancer, he spent many hours per day on his cell phone, odds are ...

  • Great article Doc. Any thoughts on Tagrisso: "In a clinical study, people taking TAGRISSO for metastatic non-small ce...

  • I reply to this comment specifically. The "CARCINOGENS IN MARIJUANA SMOKE" are to a large extent overcome in the user b...

  • Genprex, Inc. (GNPX) - Rodney Varner, Chairman and CEO, remarked during the recent Clinical and Corporate Update for Sec...

  • Please #StandWithMe in #Actions & #Prayers that my #BrotherInChrist, Charles Hielscher IS #HEALED, MADE Whole In The Na...

  • Yeah, but the 5 year survival rate for non-early stage lung cancer is still a joke. Over the past 35 years I have lost ...

  • $SIX:MOLN > INTERIM MANAGEMENT STATEMENT Q1 2018 http://e1.marco.ch/publish/konsulenten/8f7bfe72/tner_interest_underlin...

  • #EndPoints Early Edition NEW Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a ...

  • $HTBX - Heat Biologics Announces Positive Interim Data from its Phase 2 Clinical Trial of HS-110 and Nivolumab in Non-Sm...

  • $HTBX - Heat Biologics Receives Recommendation from Independent Data Monitoring Committee to Continue Enrollment of Phas...

  • Most of the potheads I knew that died didn't die of cancer. They died of liver disease from alcohol. It's a horrible d...

  • $HTBX long Some Salient points regarding Heat biologics 1) The company is evaluating the lead product 110 in combin...

  • $HTBX LONG 30-Jan-2018:07:00:00, Heat Biologics to Host Analyst and Investor Event February 28, 2018 to Present Re...

  • $NT. Dr. KSS. About 30 years ago a Dr. client of mine who smoked got lung cancer and told me he was going to beat it wi...

  • NEW Looking for a come-from-behind win, Roche touts its pivotal success for Tecentriq combo in front-line lung cancer...

  • $HTBX #HeatBiologics Receives #FDA Guidance at Type C Meeting for HS-110 Clinical Trial in the Treatment of Non-small Ce...

  • Abivax shares under pressure this morning on news being reported by Bloomberg that a lung cancer patient treated with $B...

  • $TRIL - Society for Neuro-Oncology 22nd Annual Meeting poster: http://s2.q4cdn.com/772010778/files/doc_presentations/20...

  • I had lung cancer, got it treated with the Cyberknife of Accuray, and have been cancer free for two years now. The treat...

  • $SNDX LONG second at peak 04:40 SNDX Syndax Pharmaceuticals presents ENCORE 601 data that continues to support...

  • $RXDX A nice interview with Ignyta’s CEO, Dr. Jonathan Lim, published in Rare Disease Report on November 8. Some Gu...

  • $HALO From their report: "In November 2015, we initiated a Phase 1b study exploring the combination of PEGPH20 and KEY...

  • $TRIL - November 18, 2017 05:00 PM PST San Francisco, CA Presenter: Zezhou Wang, Ph.D., Trillium Research Scientist h...

  • Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure? https://www.forbes.com/forbes/wel...

  • $LUNG - PROLUNG SETS TERMS FOR $7 MILLION IPO October 17, 2017 ProLung, which is developing a test that predicts early...

  • RXDX - Interim Analysis of Ignyta's Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therap...

  • RXDX long Ignyta has updated ongoing Phase 2 data for entrectinib. The results appear to be very positive and in lin...

  • Long $ MRTX Mirati Therapeutics price target raised to $20 from $13 at SunTrust SunTrust analyst Peter Lawson rais...

  • Long. $Rxdx Follow to Ling Ling Post Ignyta Highlights from Our KOL Call on the ROS1 / TRK Space - ALERT Last we...

  • $RXDX Ignyta’s (RXDX) Buy Rating Reaffirmed at J P Morgan Chase & Co, PT=$20 Friday, October 13th, 2017 J P...

  • $MRTX Mirati Therapeutic’s Mocetinostat was selected to participate in the prestigious SU2C program to bring cuttin...

  • $BIOC - Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board http://www.prne...

  • $ MRTX LONG Mirati Therapeutics data likely to be positive, says SunTrust SunTrust analyst Peter Lawson believes...

  • $RXDX - Ignyta Announces Updated Data on Entrectinib in ROS1 NSCLC to Be Presented at the IASLC 18th World Conference on...

  • $MRTX More details about the Oppenheimer coverage: "Oppenheimer analyst Leah R. Canninitiated coverage with a Buy...

  • $MRTX Doc, many thanks for your insightful comments. As I understand it the detailed data set will be, or has been, r...

  • $MTRX np - Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-S...

  • $RXDX (Great new data! RXDX up 9.5% in PM) Ignyta Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Co...

  • $RXDX - Ignyta Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Congress http://www.businesswire.com/news/...

  • $RXDX - gnyta Provides Regulatory Update on Entrectinib ROS1 Lung Cancer Development Program https://ignyta.com/investo...

  • $RXDX - Ignyta to Host Conference Call and Webcast on Entrectinib ROS1 Lung Cancer Update on September 6, 2017 SAN DI...

  • $RXDX long. Ignyta to Host Conference Call and Webcast on Entrectinib ROS1 Lung Cancer Update on September 6, 2017 SA...

  • I smoked from teenage years until 1989 and kept having trouble with my tonsils every year i was diagnosed with asymmetri...

  • $BIOC np - Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lun...

  • $TRIL $CD47 Ladenburg report on Trillium's 2nd quarter: (8/12) In excerpts: 2Q17 Results. TRIL reported a net lo...

  • New genes discovered regulating brain metastases in lung cancer patients https://www.sciencedaily.com/releases/2017/08/...

  • $KALA ? np - Protein nanocages that penetrate airway mucus and tumor tissue http://www.pnas.org/content/114/32/E6595.a...

  • $RXDX long - https://ignyta.com/investors/press-release-article/1036548/ Company Highlights Updated Progress Towar...

  • We've said it before: PD-1 checkpoint inhibitors ARE NOT created equal though they "seem" to act on the same pathway. Ca...

  • $SNDX- Yes this is 2 separate data readouts. SNDX's Entinostat has a breast cancer trial going on as well as an Imunoonc...

  • $TRIL Trillium Provides Update on Small Molecule Programs In excerpts: "Trillium has applied its unique medicin...

  • The latest in precision medicine for lung cancer. http://blog.aacr.org/fda-approves-new-lung-cancer-treatment-and-first...

  • Todd, I just read your post on the main thread, and I am so glad for you to hear of such hope for your wife's cure. It...

  • A close friend of mine has ALK lung cancer. Do you know of any biotechs Working on this cancer?...

  • $AFMD Long - sorry for the long post but it took me awhile to locate the abstracts so I thought I'd post for others who ...

  • I need to take my daughter to the dentist, but wanted to throw this out there--yesterday (or this morning?) $VBLT releas...

  • Another political scam. Big Tobacco money was supposed to help victims fight lung cancer and other medical conditions...

  • $TRIL: a recent report from Ladenburg Thalmann, post-ASCO17 TRILLIUM THERAPEUTICS INC. TTI-621 Expands Several New...

  • $LOXO: Paradigm shift's afoot at Biotech's most prestigous conference ASCO17 with Gene-targeted or "tissue agnostic" whe...

  • Thanks Doc. I do have a question (or series of questions), but it is/they are so basic that I am wary about taking up ev...

  • $SNDX Syndax Pharmaceuticals (SNDX): Early Ph2 Data Encouraging - Citi's new TP=>$24 May 18, 2017 7:25 AM Ci...

  • $SNDX Announces Advancement of ENCORE 601 in Non-Small Cell Lung Cancer Patients with Disease Progression on or After PD...

  • $ VBLT Long 11-May-2017:07:00:00, VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor...

  • $BIOC long - The Addario Lung Cancer Medical Institute and Biocept Announce Collaboration and Initiation of Landmark ALC...

  • $BIOC news,,,I apologize if this has been posted. Seems long term agreement with $CPRX to test small cell lung cancer pa...

  • $BIOC long - Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Canc...

  • $TSRO: TESARO Announces Fourth-Quarter 2016 Operating Results (2/28) HIGHLIGHTS: --Niraparib: NDA under review ...

  • I am sorry if I offended you Dave, I never knew your grandmother, so I was not casting aspersions on her lifestyle, but ...

  • $RXDX Long. Ignyta continues to climb, up another 10% today ($9.35). I have no special insight into long-term valuation ...

  • $CLRB long my first post here, asking for some insights to understand each segments of their business better. 1. live...

  • Gild: ''Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within' Following its 'kitchen sink' HCV guidance a...

  • Hi Doc, Thanks for the information. Again, I am skeptical, this one violates my "well-traveled drug" rule. It was approv...

  • Hi I have lung cancer been doing treatment no longer working would like to try this alpha cells treatment...

  • Bristol has abandoned plans to study nivolumab and Yervoy in lung cancer. But is not saying why so as "to protect the in...

  • Bloomberg's take on this development: "Bristol-Myers Falls Further Behind Merck in Lung Cancer Race" The shares fe...

  • Hi Everyone, FDA locked the gate on $BMY front-line lung cancer Tx. (Opdivo + Yervoy Accelerated pathway abandoned) in...

  • News report: Study suggests small cell lung cancer should not be treated as single disease http://www.cancerresearchuk....

  • Biotech is our chance for real cures, IMO - such as for cancer. My poor brother has small cell lung cancer, and if the...

  • A new research report on $MRK issued by BMO Capital on 1/10/17: "In Position to Meaningfully Strengthen Leadership ...

  • Berberine. Here is what I found at LEF.Com. Berberine is an alkaloid found in various different medicinal herbs. Prob...

  • $BIOC long and so is this post: Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biop...

  • PD-1 protein could serve as biomarker for predicting survival of lung cancer patients https://twitter.com/weldeiry/stat...

  • Thanks, Blue. Great article. Cimavax was developed to combat the high rate of lung cancer, which is understandable given...

  • I note that the NY Times and other papers have articles regarding cimavax, a Cuban vaccine to slow development of lung c...

  • CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer. http://www.sigmaaldrich.com/catalog/papers/27...

  • My brother was on nivolumab (lung cancer) and was taken off after having some of the more severe symptoms, and is still...

  • Merck with Keytruda wins early US approval with those with untreated lung cancer. http://www.reuters.com/article/us-m...

  • $BIOC no position. Good news. Biocept announces that clinical results from a study evaluating 40 patients with advanc...

  • $BMY's opdivo is still a good drug and valuable asset to the company, but data released since summer and confirmed last ...

  • I'm confused as to the recent Opdivo (nivolumab) conflicting news. One report says that this $BMY immunotherapy is a ga...

  • $BIOC - Clinical Results Demonstrating the Performance of Biocept's Target Selector Platform to be Presented at the 2016...

  • $KPTI - Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor's Potential in KRAS-Mutant Non-Small Cel...

  • $RXDX - an interesting new article on Ignyta that provides excellent insights into the company’s past, present. and fu...

  • When Breath Becomes Air by Paul Kalanithi is an amazing book about death. "At the age of thirty-six, on the verge of...

  • Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer? https://twitter....

  • Back in February I bought the US version of Pharmamar with symbol PHMMF. It tracks the Madrid version . I paid $2.60 an...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info